Some of the bankrupt company’s closest rivals, newer telehealth firms, face a new challenge of their own as federal ...

Everyone's weight loss and health journey looks different, and these celebrities have spoken out about their own paths ...

Eli Lilly's experimental pill worked as well as blockbuster drug Ozempic to lower weight and blood sugar in a trial of diabetes patients, and the company said it expects to seek regulatory approvals ...

A daily pill developed by the US pharmaceutical company Lilly may become a convenient alternative to injectable drugs like ...

Some experts say oral versions of popular weight-loss drugs such as Wegovy could offer people more flexibility and accessibility. What’s keeping the pills from taking off?

A recent medical trial could help deliver the first daily weight loss pill capable of cutting down obesity as effectively as Ozempic.

Eli Lilly GLP-1 pill orforglipron could revolutionize the weight loss world by the end of 2025 after promising Phase 3 trial ...

Yet, slimmers trying a new weight-loss pill called Sirona — so far available ... from 2022 of semaglutide — the active ingredient in Ozempic — showed it could help users shed around ...

Eli Lilly's experimental oral pill, orforglipron ... become a hassle-free and effective alternative to other weight-loss drugs such as Ozempic and Mounjaro. In a 40-week Phase 3 trial, they ...

Eli Lilly has seen positive results from a phase 3 trial of Orforglipron, the first-ever GLP-1 pill for weight loss and type 2 diabetes. Previous versions were administered via injection.